Viavi Solutions heads into Thursday's post-close earnings release as one of the clearest short-covering stories in the communications equipment space — a 31% monthly price run paired with a meaningful unwind of bearish positions, just as the company delivered on its numbers.
The headline from the release was unambiguous. Viavi posted fiscal Q3 adjusted EPS of $0.27 against a $0.23 consensus estimate, with revenue of $406.8M clearing the $393.8M bar. Guidance for Q4 FY2026 came in at $427M–$437M revenue and EPS of $0.29–$0.31, with management citing continued data centre demand as a growth driver. The stock jumped approximately 12.6% in after-hours trading following the print, extending a move that has already been underway for weeks.
The short interest picture tells that story in its own way. Bears have been retreating steadily. SI as a percentage of free float has fallen from a peak near 8.2% on April 9 to 6.2% by April 28 — a drop of roughly two percentage points over three weeks. In raw share terms, the short count declined nearly 14% over the past week alone, with the bulk of that covering concentrated around April 22–24, right as the stock was breaking higher. Borrow costs remain negligible at around 0.43% — there is no squeeze premium here. Shorts have been leaving because the trade isn't working, not because they've been forced out. Availability in the lending market remains loose, consistent with a stock where the remaining short base has plenty of room to exit if they choose.
Options positioning has shifted in a notably defensive direction, though the timing makes this read somewhat ambiguous now that earnings have passed. The put/call ratio hit 0.48 — its highest reading of the past year — just ahead of the print, running well above its 20-day average of 0.40 at roughly 1.5 standard deviations elevated. That hedging demand likely reflected uncertainty going into the result rather than a genuine bear conviction; with the beat now on the table, those protective puts may unwind quickly.
Analysts have been chasing the stock higher throughout the move, though several targets already look stale relative to where shares are now trading. B. Riley's Dave Kang stands out: on April 24 he raised his target from $26 to $53 while maintaining a Buy, an unusually large revision that now sits above the current $45.53 close. Rosenblatt and Needham both lifted targets in March — to $42 and $36 respectively — moves that looked aggressive at the time but have since been absorbed by the price action. The consensus mean target is $44.00, fractionally below Wednesday's close, which means the Street as a whole is now neutral on the next leg. The bull case centres on 5G test and monitoring demand and the growing aerospace/defence Resilient PNT business; the bear case flags operational complexity in the service enablement restructuring and margin risk in the shift toward a software-centric model. With the stock now above the consensus target, valuation has moved into the conversation: the trailing P/E has expanded to over 50x and the EV/EBITDA multiple is running at 32x, both up roughly 12–13 points over the past month.
Institutional flows add texture to the broader ownership picture. T. Rowe Price added nearly 1.95 million shares in Q1, a meaningful increase, while Columbia Management added 2.18 million shares — both building into the strength. BlackRock and Vanguard, the two largest holders at 14.4% and 12.7% respectively, also added modestly. Against that backdrop, insider selling from earlier in the quarter stands out. CEO Oleg Khaykin sold approximately 166,000 shares across several transactions in early February at prices between $26 and $27.50, raising around $4.4M — sales that look prescient in one direction, though they predate the bulk of the rally by several weeks.
The January earnings print is the only clean historical reaction on file. That Q2 result delivered a 16% single-day move and a 20% five-day gain — an outsized read-through that likely contributed to both the institutional accumulation and the short covering seen through March and April. With Q3 now comfortably ahead of estimates and Q4 guidance above consensus, the next question is whether institutional buyers who chased the stock into the $40s are willing to continue building above the Street's average target, or whether analyst upgrades with fresh and higher price objectives begin to provide new cover for the next leg of the move.
See the live data behind this article on ORTEX.
Open VIAV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
